Literature DB >> 31099386

TPES: tumor purity estimation from SNVs.

Alessio Locallo1, Davide Prandi1, Tarcisio Fedrizzi1, Francesca Demichelis1,2,3.   

Abstract

MOTIVATION: Tumor purity (TP) is the proportion of cancer cells in a tumor sample. TP impacts on the accurate assessment of molecular and genomics features as assayed with NGS approaches. State-of-the-art tools mainly rely on somatic copy-number alterations (SCNA) to quantify TP and therefore fail when a tumor genome is nearly euploid, i.e. 'non-aberrant' in terms of identifiable SCNAs.
RESULTS: We introduce a computational method, tumor purity estimation from single-nucleotide variants (SNVs), which derives TP from the allelic fraction distribution of SNVs. On more than 7800 whole-exome sequencing data of TCGA tumor samples, it showed high concordance with a range of TP tools (Spearman's correlation between 0.68 and 0.82; >9 SNVs) and rescued TP estimates of 1, 194 samples (15%) pan-cancer.
AVAILABILITY AND IMPLEMENTATION: TPES is available as an R package on CRAN and at https://bitbucket.org/l0ka/tpes.git. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31099386      PMCID: PMC6821153          DOI: 10.1093/bioinformatics/btz406

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  11 in total

1.  Allele-specific copy number analysis of tumors.

Authors:  Peter Van Loo; Silje H Nordgard; Ole Christian Lingjærde; Hege G Russnes; Inga H Rye; Wei Sun; Victor J Weigman; Peter Marynen; Anders Zetterberg; Bjørn Naume; Charles M Perou; Anne-Lise Børresen-Dale; Vessela N Kristensen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

2.  PurityEst: estimating purity of human tumor samples using next-generation sequencing data.

Authors:  Xiaoping Su; Li Zhang; Jianping Zhang; Funda Meric-Bernstam; John N Weinstein
Journal:  Bioinformatics       Date:  2012-06-28       Impact factor: 6.937

3.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.

Authors:  Craig H Mermel; Steven E Schumacher; Barbara Hill; Matthew L Meyerson; Rameen Beroukhim; Gad Getz
Journal:  Genome Biol       Date:  2011-04-28       Impact factor: 13.583

4.  Inferring tumour purity and stromal and immune cell admixture from expression data.

Authors:  Kosuke Yoshihara; Maria Shahmoradgoli; Emmanuel Martínez; Rahulsimham Vegesna; Hoon Kim; Wandaliz Torres-Garcia; Victor Treviño; Hui Shen; Peter W Laird; Douglas A Levine; Scott L Carter; Gad Getz; Katherine Stemke-Hale; Gordon B Mills; Roel G W Verhaak
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.

Authors:  F Favero; T Joshi; A M Marquard; N J Birkbak; M Krzystanek; Q Li; Z Szallasi; A C Eklund
Journal:  Ann Oncol       Date:  2014-10-15       Impact factor: 32.976

6.  Absolute quantification of somatic DNA alterations in human cancer.

Authors:  Scott L Carter; Kristian Cibulskis; Elena Helman; Aaron McKenna; Hui Shen; Travis Zack; Peter W Laird; Robert C Onofrio; Wendy Winckler; Barbara A Weir; Rameen Beroukhim; David Pellman; Douglas A Levine; Eric S Lander; Matthew Meyerson; Gad Getz
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

7.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.

Authors:  Zachary R Chalmers; Caitlin F Connelly; David Fabrizio; Laurie Gay; Siraj M Ali; Riley Ennis; Alexa Schrock; Brittany Campbell; Adam Shlien; Juliann Chmielecki; Franklin Huang; Yuting He; James Sun; Uri Tabori; Mark Kennedy; Daniel S Lieber; Steven Roels; Jared White; Geoffrey A Otto; Jeffrey S Ross; Levi Garraway; Vincent A Miller; Phillip J Stephens; Garrett M Frampton
Journal:  Genome Med       Date:  2017-04-19       Impact factor: 11.117

8.  Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data.

Authors:  Jacob F Degner; John C Marioni; Athma A Pai; Joseph K Pickrell; Everlyne Nkadori; Yoav Gilad; Jonathan K Pritchard
Journal:  Bioinformatics       Date:  2009-10-06       Impact factor: 6.937

9.  Systematic pan-cancer analysis of tumour purity.

Authors:  Dvir Aran; Marina Sirota; Atul J Butte
Journal:  Nat Commun       Date:  2015-12-04       Impact factor: 14.919

10.  Unraveling the clonal hierarchy of somatic genomic aberrations.

Authors:  Davide Prandi; Sylvan C Baca; Alessandro Romanel; Christopher E Barbieri; Juan-Miguel Mosquera; Jacqueline Fontugne; Himisha Beltran; Andrea Sboner; Levi A Garraway; Mark A Rubin; Francesca Demichelis
Journal:  Genome Biol       Date:  2014-08-26       Impact factor: 13.583

View more
  6 in total

1.  Purity estimation from differentially methylated sites using Illumina Infinium methylation microarray data.

Authors:  Riasat Azim; Shulin Wang; Su Zhou; Xing Zhong
Journal:  Cell Cycle       Date:  2020-07-05       Impact factor: 4.534

2.  Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis.

Authors:  Maximilian O Schaettler; Megan M Richters; Malachi Griffith; Gavin P Dunn; Anthony Z Wang; Zachary L Skidmore; Bryan Fisk; Katherine E Miller; Tammi L Vickery; Albert H Kim; Michael R Chicoine; Joshua W Osbun; Eric C Leuthardt; Joshua L Dowling; Gregory J Zipfel; Ralph G Dacey; Hsiang-Chih Lu; Tanner M Johanns; Obi L Griffith; Elaine R Mardis
Journal:  Cancer Discov       Date:  2021-10-05       Impact factor: 38.272

3.  Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.

Authors:  Louise de Schaetzen van Brienen; Maarten Larmuseau; Kim Van der Eecken; Frederic De Ryck; Pauline Robbe; Anna Schuh; Jan Fostier; Piet Ost; Kathleen Marchal
Journal:  BMC Med Genomics       Date:  2020-07-06       Impact factor: 3.063

4.  Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer.

Authors:  Yari Ciani; Tarcisio Fedrizzi; Davide Prandi; Francesca Lorenzin; Alessio Locallo; Paola Gasperini; Gian Marco Franceschini; Matteo Benelli; Olivier Elemento; Luca L Fava; Alberto Inga; Francesca Demichelis
Journal:  Cell Syst       Date:  2021-11-02       Impact factor: 10.304

5.  Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy.

Authors:  Julianna K Bronk; Chiraag Kapadia; Xiaogang Wu; Bhavana V Chapman; Rui Wang; Tatiana V Karpinets; Xingzhi Song; Andrew M Futreal; Jianhua Zhang; Ann H Klopp; Lauren E Colbert
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

6.  Variant calling enhances the identification of cancer cells in single-cell RNA sequencing data.

Authors:  William Gasper; Francesca Rossi; Matteo Ligorio; Dario Ghersi
Journal:  PLoS Comput Biol       Date:  2022-10-03       Impact factor: 4.779

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.